Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Oruka Therapeutics Inc ORKA

Healthcare Biotechnology
Oruka Therapeutics, Inc., formerly ARCA biopharma, Inc., is a biotechnology company. The Company is engaged in developing novel biologics designed for the treatment of chronic skin diseases, including plaque psoriasis. It is advancing a proprietary portfolio of potential antibodies that target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. The... see more

Recent & Breaking News (NDAQ:ORKA)

Oruka Therapeutics to Present at Piper Sandler's 36th Annual Healthcare Conference

GlobeNewswire 10 days ago

Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire November 13, 2024

Oruka Therapeutics to Present at Multiple November Investor Conferences

GlobeNewswire November 4, 2024

Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress

GlobeNewswire September 25, 2024

Oruka Therapeutics Announces $200 Million Private Placement

GlobeNewswire September 12, 2024

Oruka Therapeutics Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001's Profile as a Potentially Best-in-Class Half-Life Extended Antibody Targeting IL-23p19

GlobeNewswire September 12, 2024

Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million

GlobeNewswire September 3, 2024

ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split

GlobeNewswire August 29, 2024

ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics

GlobeNewswire August 26, 2024

ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics

GlobeNewswire August 23, 2024

ARCA biopharma Declares Special Dividend in Connection with the Proposed Merger with Oruka Therapeutics

GlobeNewswire August 16, 2024

ARCA biopharma Announces Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire August 1, 2024

SHAREHOLDER UPDATE: Halper Sadeh LLC Continues to Investigate ABIO, MODN, DPSI, AIRC

PR Newswire June 5, 2024

Shareholder Alert: Ademi LLP investigates Disclosure Issues involving ARCA biopharma, Inc.'s Transaction with Oruka

PR Newswire June 4, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, HIBB, ABIO, HMNF

PR Newswire May 23, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, ABIO, SSB, HMNF

Accesswire May 22, 2024

Kuehn Law Encourages ABIO, SQSP, SSB, and HMNF Investors to Contact Law Firm

PR Newswire May 22, 2024

ARCA BIOPHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO

Business Wire May 10, 2024

ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire April 25, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANSS, HRT, CHX, ABIO

PR Newswire April 10, 2024